¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"type III hypersensitivity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • wild type strain
    ¾ß»ýÁÖ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • split-electrode-type probe
    ºÐÇÒÀü±Ø´õµëÀÚ
  • storage-type
    ÃàÀûÇü
  • scirrhous type
    °æÈ­Çü
  • simple type schizophrenia
    ´Ü¼øÁ¤½ÅºÐ¿­º´
  • sthenic type
    ±Ù·ÂÇü
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü
  • type species
    Ç¥ÁرÕÁ¾
  • type specificity
    ÇüƯÀ̼º
  • type specimen
    ±âÁØÇ¥º»
  • type strain
    Ç¥ÁرÕÁÖ
  • type
    Çü, À¯Çü
  • test type
    ½Ã°¢Ç¥, ½ÃÇ¥
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Mobitz type II AV block
    ¸ðºñÃ÷ ¥±Çü ¹æ½ÇÂ÷´Ü.
  • Mobitz type II SA block
    ¸ðºñÃ÷ ¥±Çü µ¿¹æÂ÷´Ü.
  • Ogawa type
    ¿À°¡¿ÍÇü
  • RF coil type
    °íÁÖÆÄ ÄÚÀÏ À¯Çü
  • T-type channel
    T-Çü Åë·Î
  • aberrant type
    ÀÌÇü(ì¶úþ)
  • abortive type
    ºÎÀüÇü(ÝÕîïúþ).
  • acute fulminating type
    ±Þ¼º Àü°ÝÇü.
  • agammaglobulinemia,x-linked, bruton type
    ¼º¿°»öü ¿¬°ü¼º, ºê·çÅæÇü(àõæøßäô÷ æáμàõ, ¡­úþ)
  • anovulatory type
    ¹«¹è¶õÇü
  • glomus type of arteriovenous anastomosis
    Å丮Çüµ¿Á¤¸Æ¿¬°á
  • golgi type i neuron
    ±äÃà»è½Å°æ¼¼Æ÷
  • golgi type ii neuron
    ªÀºÃà»è½Å°æ¼¼Æ÷
  • growth onset type diabetes
    Ãʱâ´ç´¢º´.
  • hebephrenic type
    ÆÄ°úÇü(÷òÍþúþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity, penicillin
    Æä´Ï½Ç¸° °ú¹Î¹ÝÀÀ
  • hypersensitivity, poison ivy
    ¿Ì °ú¹Î¹ÝÀÀ
  • hypersensitivity, pollen
    ²É°¡·ç °ú¹Î¹ÝÀÀ, ²É°¡·ç ¾Ë·¹¸£±â
  • hypersensitivity, tuberculin
    Åõº£¸£Ä𸰠°ú¹Î¹ÝÀÀ
  • immediate hypersensitivity
    Áï½ÃÇü°ú¹Î¹ÝÀÀ
  • immediate hypersensitivity
    Áï½Ã(Çü)°ú¹ÎÁõ(ñíãÁúþΦÚÂñø).
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³ °ú¹Î¹ÝÀÀ
  • rejection, hypersensitivity to
    °ÅºÎ¿¡ ´ëÇÑ °ú¹Î(-¼º)
  • streptococcal hypersensitivity
    ¿¬¼â±¸±Õ°ú¹Î¼º(¡­Î¦ÚÂàõ).
  • tuberculin hypersensitivity
    Åõº£¸£Ä𸰰ú¹ÎÁõ(¡­Î¦ÚÂñø), Åõº£¸£Ä𸰰ú¹Î¹ÝÀÀ
  • tuberculin hypersensitivity
    Åõº£¸£Ä𸰰ú¹ÎÁõ(¡­Î¦ÚÂñø).
  • tuberculin hypersensitivity
    Åõº£¸£Ä𸰰ú¹ÎÁõ(¡­Î¦ÚÂñø).
  • tuberculin hypersensitivity
    Åõº£¸£Ä𸰰ú¹Î Áõ(¡­Î¦ÚÂñø).
  • aberrant type
    ÀÌÇü(ì¶úþ)
  • abortive type
    ºÎÀüÇü(ÝÕîïúþ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
III-para tertipara
MS I, II, III, IV medical student-first, second, third, and fourth year
para III tripara
TCIII transcobalamin III
HP Hypersensitivity Pneumonitis
  = Extrinsic Allergic Alveolitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
JH III Juvenile hormone III
pol III Polymerase III
P-III-P precollagen-III-peptide
PDE III phosphodiesterase III
URO-III-S uroporphyrinogen III synthase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • muscular type of vein
    ±ÙÀ°Çü Á¤¸Æ
  • nonnecrotizing type
    ºñ±«»ç¼º ÇüÅÂ
  • oral-facial-digital syndrome, type I
    IÇü±¸-¾È¸é-ÁöÁõÈıº
    X-¿¬°ü¼º ¿ì¼º À¯Àüº´À¸·Î¼­ ³²ÀÚ¿¡°Ô´Â Ä¡¸íÀûÀ¸·Î ±¼ÁöÁõ, ´ÙÁöÁõ, ÇÕÁöÁõ µîÀÌ Æ¯Â¡À̸ç, µÎ°³, ¾È¸é, ¼³, ±¸°³ ¹× ÇÏ¾Ç ±âÇüÀ» ¼ö¹ÝÇϰųª Áö´É ÀúÇÏ, Å»¸ðÁõ, ¾È¸é Áö·ç¸¦ ¼ö¹ÝÇÑ´Ù.
  • pedunclated type
    À¯°æÇü
  • personality type
    Àμº
  • pontic of root extension type
    À¯±Ù °¡°øÃ¼
    ¼ÒÇüÀÇ Ä¡±ÙÀ» °¡Áö°í ¹ßÄ¡¿Í ¼Ó¿¡ ÀûÇյǴ °¡ °øÃ¼, Ä¡°æºÎ¿Í ÇüÅ ±×¸®°í Ä¡Àº¿¬°úÀÇ °ü°è°¡ ÀÚ¿¬¿¡ °¡±õ°í ½É¹ÌÀûÀÌ°í °¡Àå ¿ì¼öÇϸç, ÀåÂø ÈÄ Ä¡ÀºÀÌ ¾à°£ ÅðÃàÇÏ¿©µµ °¡°øÃ¼¿ÍÀÇ »çÀÌ¿¡ °ø±ØÀÌ »ý±âÁö ¾Ê°í »ç¿ë°¨µµ ¾çÈ£ÇÏ´Ù. ´ë°³ Áï½Ã °¡°ø ÀÇÄ¡·Î¼­ ¹ßÄ¡ Á÷ÈÄ¿¡ ÀåÂøµÈ´Ù.
  • precision type attachment
    Á¤¹ÐÇü ºÎÂø ÀåÄ¡
  • pseudohypertrophic type
    °¡¼º ºñ´ëÇü
  • recurring type
    Àç¹ß¼º
  • repository type of penicillin
    ÀúÀåÇü Æä´Ï½Ç¸°
  • salivary gland type
    Ÿ¾×¼± À¯Çü
  • schizoaffetive type
    ºÐ¿­ Á¤µ¿Çü, ºÐ¿­ Á¤°¨Çü
  • schizoid type
    ºÐ¿­Çü
  • schizophrenia of childhood type
    ¾Æµ¿Çü Á¤½Å ºÐ¿­Áõ
    »çÃá±â¿¡ ¹ßº´ÇÏ´Â Á¤½Å ºÐ¿­ÁõÀ¸·Î¼­ ÀÚÆó¼º, ³»Ç⼺, ºñÁ¤ÇüÀû ÇൿÀ» Ư¡À¸·Î ÇÑ´Ù.
  • screen-type cassette
    ½ºÅ©¸°Çü Ä«¼¼Æ®
    ´ë°Ô ±Ý¼ÓÀ¸·Î ¸¸µé¾î Á³À¸¸ç, ³ëÃâ¸éÀº º£ÀÌŬ¶óÀÌÆ®, ¾Ë·ç¹Ì´½, ¸¶±×³×½·°ú °°Àº ³·Àº ¿øÀÚ ¹øÈ£ÀÇ ¹°Áú·Î µÇ¾î ÀÖ°í, Áõ°¨Áö¸¦ Æ÷ÇÔÇϰí À־ ±× »çÀÌ¿¡ X-¼± ³ëÃâÀ» À§ÇÑ "½ºÅ©¸°Çü" Çʸ§À» À§Ä¡½ÃŲ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
HTLV-III <abbreviation> Human T-cell lymphotropic virus type III.
See: human immunodeficiency virus.
(05 Mar 2000)
NADH-Fe(III)EDTA oxidoreductase <enzyme> From cryptococcus albidus; catalyses the formation of nad+ and fe(ii)edta from NADH and fe(iii)edta; forms ethylene from 2-oxo-4-methylthiobutyric acid
Registry number: EC 1.6.99.-
(26 Jun 1999)
Sudan III A red stain, (C6H5)N==N(C6H4)N==N(C10H6)OH, used for neutral fat in histologic technique; it also stains the fatty envelope of the tubercle bacillus.
Synonym: Sudan red III.
(05 Mar 2000)
Sudan red III A red stain, (C6H5)N==N(C6H4)N==N(C10H6)OH, used for neutral fat in histologic technique; it also stains the fatty envelope of the tubercle bacillus.
Synonym: Sudan red III.
(05 Mar 2000)
DNA polymerase III <enzyme> An enzyme that aids in DNA replication. It has a number of different functions, such as: proofreading newly replicated DNA, removing nucleotides from the 3' end of the strand one by one, and binding nucleotides from the 5' end of the strand.
(09 Oct 1997)
ductus pharyngobranchialis III A narrow communication between the third branchial pouch and the pharynx in the embryo.
(05 Mar 2000)
exonuclease III An exonuclease enzyme which removes nucleotides one at a time from the 5'-end of duplex DNA which does not have a phosphorylated 3'-end.
(09 Oct 1997)
factor III In the clotting of blood, tissue factor or thromboplastin; it initiates the extrinsic pathway by reacting with factor VII and calcium to form factor VIIa.
See: thromboplastin.
(05 Mar 2000)
uroporphyrin-III C-methyltransferase <enzyme> From pseudomonas denitrificans; enzyme of the cobalamin biosynthetic pathway which catalyses the c methylation of uroporphyrinogen III; also catalyses both nad+ dependent oxidation of precorrin-2 to sirohydrochlorin and insertion of iron into it to produce siroheme; cysg gene is from E coli; product of coba gene of pseudomonas; do not confuse with coba gene product of salmonella typhimurium which yields ATP-corrinoid adenosyltransferase
Registry number: EC 2.1.1.107
Synonym: uroiii methyltransferase, uroporphyrinogen III methylase, sumt methyltransferase, s-adenosylmethionine-uroporphyrinogen III methyltransferase, cysg gene product, siroheme synthase, coba gene product, propionibacterium
(26 Jun 1999)
uroporphyrinogen-III synthase <enzyme> An enzyme that catalyses the cyclization of hydroxymethylbilane to yield uroporphyrinogen III and water.
Chemical name: Hydroxymethylbilane hydro-lyase (cyclizing)
Registry number: EC 4.2.1.75
(12 Dec 1998)
forms of DNA i, II and III Refers to circular DNA removed from viruses and as plasmids. Form I is the DNA in its normal, supercoiled form. Form II is the DNA after one of the two strands has been nicked (cut apart), and is circular. Form III is the DNA after both strands have been broken, and is linear.
(09 Oct 1997)
Le Fort III craniofacial dysjunction A complex fracture in which the facial bones are separated from the cranial bones.
Synonym: Le Fort III craniofacial dysjunction, Le Fort III fracture, transverse facial fracture.
(05 Mar 2000)
Le Fort III fracture A complex fracture in which the facial bones are separated from the cranial bones.
Synonym: Le Fort III craniofacial dysjunction, Le Fort III fracture, transverse facial fracture.
(05 Mar 2000)
acrocephalosyndactyly type 1 <paediatrics> An inherited disease (autosomal dominant) or a spontaneously occurring disease characterised by a peaked head and unusual facial appearance, due to the premature closure of the cranial sutures.
A skull X-ray can confirm the diagnosis and treatment is surgical.
Inheritance: autosomal dominant.
(27 Sep 1997)
Alzheimer type I astrocyte Enlarged frequently multinucleated astrocytes, seen in progressive multifocal leukoencephalopathy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á